Sumitomo Chemical India has scheduled an earnings call to discuss its financial performance for the quarter and year ended March 31, 2026. The meeting will be held on Thursday, May 28, 2026, at 2:00 pm IST. This initiative is pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The conference call will provide a platform for investors and analysts to engage with the company's management regarding the results for Q4FY26 and the full fiscal year. The specific agenda includes a review of the financial outcomes and operational highlights for the periods under consideration.

Access details for the earnings call, including registration links and dial-in numbers, have been made available through an official invite. The company has also hosted the invite on its official website to ensure broad accessibility for all stakeholders.

Earnings Call Details

The disclosure was formally communicated to the stock exchanges, BSE Limited and the National Stock Exchange of India, by Deepika Trivedi, Company Secretary of Sumitomo Chemical India Limited.

Sumitomo Chemical India has reported a consolidated net profit of ₹543 crore for the financial year ended March 31, 2026, an increase of 7% from ₹506.4 crore in the previous year. Revenue from operations for the year rose 3% to ₹3,238.3 crore, compared to ₹3,148.5 crore in FY25. Profit before tax for the year stood at ₹727.6 crore, up from ₹680.2 crore in the prior year. The Board of Directors has declared a final dividend of ₹1.30 per equity share, subject to shareholder approval, aggregating to ₹648.89 million. The company has scheduled an earnings call with investors and analysts to discuss the financial performance for the quarter and year ended March 31, 2026, on May 28, 2026, at 2:00 pm IST.

The company's standalone net profit for FY26 was ₹543.1 crore, compared to ₹501.9 crore in the previous year. Standalone revenue from operations increased to ₹3,185.8 crore from ₹3,090.4 crore in FY25. The financial results were reviewed by the Audit Committee and approved by the Board on May 26, 2026. An investor presentation for the quarter and year ended March 31, 2026, was submitted to the exchanges on May 27, 2026.

Annual Financial Performance

Q4 Quarterly Performance

Sumitomo Chemical India's quarterly performance also reflected improvement. The company's Q4 EBITDA rose to ₹134.2 crore versus ₹119.6 crore in the same period of the previous year, with the EBITDA margin expanding to 19.6% from 17.6% year-on-year.

Segment and Operational Details

Sumitomo Chemical India operates a single reportable segment, agro-chemicals. The company noted that its business is seasonal in nature and performance depends on monsoon and climatic conditions. During the quarter ended December 31, 2025, the company recognised an exceptional item of ₹16.1 crore related to the incremental impact of the new Labour Codes notified by the Government of India.

Board Reconstitution

The Board of Directors has approved the reconstitution of the board effective September 1, 2026. Mr. Mukul Govindji Asher's current and final term as Independent Director and Chairman will be till August 31, 2026. Mr. Chetan Shantilal Shah's current and final term as Managing Director will be till August 31, 2026, following which he is proposed to be appointed as Non-Executive Non-Independent Director. Dr. Suresh Ramachandran is proposed to be appointed as Managing Director with effect from September 1, 2026.